Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2008
11/12/2008EP1989175A1 Method for producing 1-formamido-3,5-dimethyladamantane
11/12/2008EP1989174A1 Substituted cyclohexylmethyl derivatives
11/12/2008EP1989162A1 Cycloalkylphenyl substituted cyclic ketoenols
11/12/2008CN201148406Y Reactor
11/12/2008CN101305023A Polymer having sulfonic acid group or sulfonic acid ester group and amide group, and toner for developing electrostatic latent image having the polymer
11/12/2008CN101304966A Organic compounds
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432045C N, N-dimethylformamide regeneration method after C5 extraction desorption
11/11/2008US7449599 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/11/2008US7449594 Process for preparing 4-pentafluorosulfanylbenzoylguanidines
11/06/2008WO2008030883A3 Treatment of cancer
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed
11/06/2008US20080274052 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide
11/06/2008DE10297824B4 Verfahren zum Einsatz von Wasserstoff zur reduktiven Acylierung von Nitro-, Azido- und Cyanarenen A method of using hydrogen for the reductive acylation of nitro, azido and cyano arenes
11/05/2008EP1986996A2 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
11/05/2008EP1781274B1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300225A Selective acylation of 4-substituted-1,3-phenylenediamine
11/05/2008CN101299920A Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
11/05/2008CN101298426A Water-soluble derivate of 2,6-diisopropyl phenol and use thereof
11/05/2008CN101298425A Preparation process of p-acetaminophenol
11/05/2008CN101298424A Preparation of capsicine
11/05/2008CN101298056A Asymmetric catalytic reaction catalyst and preparation and use thereof
11/05/2008CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/04/2008US7446226 Phenylhept-6-yne-acid-4-hydroxy-3-methoxylbenzylamide (phenylcapsaicin); use as microorganism repellent agents in paints and coatings, for marine installations and ships, but also for land-based structures; nontoxic
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
10/2008
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008WO2007126362A8 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
10/30/2008US20080269500 Process for the Preparation of 4-Aminopyrazole Derivatives
10/30/2008US20080269382 against oxidative, thermal or light-induced degradation, by applying stabilizers agents such as 2-phenyl-acrylic Acid Octyl Ester
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269324 long chain retinyl ketone, ester, amide, retinimide etc. free of N-(4-hydroxyphenyl)retinamide); inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/30/2008US20080268138 Metal plating compositions and methods
10/30/2008US20080268073 derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, Rutaceae, Laminariaceae, Myrtaceae and Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1984327A2 An improved process for the preparation of cilastatin and sodium salt
10/29/2008EP1984325A2 Sulfonanilide analogs as selective aromatase modulators
10/29/2008EP1984323A1 Viral polymerase inhibitors
10/29/2008EP1984322A1 Benzamide and heteroarene derivatives
10/29/2008EP1633762B1 Paracyclophanes
10/29/2008EP1513892B1 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof
10/29/2008EP1492776B1 Iodinated triglyceride analogs
10/29/2008EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives
10/29/2008CN101296897A PPAR modulating biaromatic compounds
10/29/2008CN101293851A (Z)-2-benzoyl-amido-4,4-difluorine-2-butenoic acid ethyl ester, cis-1-benzoyl-amido-2-difluorine methyl cyclopropane-carboxylic acid ethyl ester and synthesizing method thereof
10/29/2008CN100429199C Process for preparing cycloalkanoimide betaine and use thereof
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442830 Proteasome inhibitors
10/28/2008US7442829 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/28/2008US7442826 esterification of 4-acetaminophenols or salts with (nitrooxy)alkanoyl chlorides or acids, to form analgesics with significantly reduced liver toxicity
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442558 Phthalamide-lanthanide complexes for use as luminescent markers
10/23/2008WO2008127728A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008101907A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2008US20080262259 Method for vegetable oil derived polyols and polyurethanes made therefrom
10/23/2008US20080262254 Sphingolipids
10/23/2008US20080262091 Analgesic/antinociceptive agents comprising 1-15,000mu g of capsaicin and other capsaicinoids in a vehicle; side effect reduction; neuropathic pain; neurotransmitter-dysregulation syndromes; incapacitation of C-fibers and/or A-delta fibers; denervate edges without eliciting an effect outside the edge
10/23/2008US20080262090 Guanylhydrazone Salts, Compositions, Processes of Making, and Methods of Using
10/23/2008US20080262083 A stereoisomer of a"Fenicol compound" (a chloramphenicol), D-(threo)-1-aryl-2-disubstituted-acylamido-3-fluoro-1-propanols; broad spectrum anibiotic with greater bioavailability; veterinary medicine; testing and administering the stereoisomer which clears more slowly; side effect reduction; nontoxic
10/23/2008US20080262046 Amidopropoxyphenyl Orexin Receptor Antagonists
10/23/2008US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
10/23/2008US20080261981 3-{4-[4-(2-amino-3-morpholin-4-yl-3-oxo-propyl)-phenoxy]-phenyl}-N-hydroxypropionamide hydrochloride; for reducing blood glucose, free fatty acids, cholesterol, triglycerides levels
10/23/2008US20080260791 Reducing pain; in situ administering dosage
10/22/2008EP1982985A2 Method for manufacturing a purine derivative
10/22/2008EP1982970A1 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
10/22/2008CN101291905A Phenyl-acetamide nnrt inhibitors
10/22/2008CN100427461C Polymerisable benzophenone photoinitiator and its preparing method
10/21/2008US7439394 Cyclohexyl-1,4-diamine compounds
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439366 Phenacylamine derivatives, process for their production and pesticides containing them
10/21/2008US7439358 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
10/21/2008US7439005 Styrene derivative, styrene polymer, photosensitive resin composition, and method for forming pattern
10/16/2008WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008082502A3 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
10/16/2008US20080255347 Process for making galantamine
10/16/2008US20080255250 Compounds and Compositions for Delivering Active Agents
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/15/2008EP1471881B1 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284798A Environmental protection synthetic method of N-acetoglycocol
10/15/2008CN101284797A Decomposing method of N-protected allyl glycinate
10/15/2008CN101284773A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
10/14/2008US7435851 Puleganic amides
10/14/2008US7435850 2-Fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide, its enantiomers, and addition salts; melatoninergic disorders, circadian rhythm disorders, antidepressants, seasonal affective disorders, sleep disorders, jetlag
10/14/2008CA2333888C Production of optically active phospholanes
10/09/2008WO2008120475A1 Method for producing alcohol by hydrogenating lactone and carboxylic acid ester in liquid phase
10/09/2008US20080249335 Antioxidants and methods of making and using the same
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 289